Find Academic Supervisors

• Neurodegenerative Diseases
• Alzheimer's Disease
• Frontotemporal Dementia
• +7 more

Dr. Henry Paulson is the Lucile Groff Professor of Neurology at the University of Michigan, where he serves as Director of the Michigan Alzheimer’s Disease Center and a Research Professor at the Michigan Neuroscience Institute. His work bridges clinical and basic research in age-related neurodegenerative diseases. Education: MD and PhD from Yale University Postgraduate Training: Clinical Fellowship in movement disorders and neurogenetics at the University of Pennsylvania Health System (1994-1997) Dr. Paulson's research focuses on: Molecular mechanisms of neurodegenerative diseases (Alzheimer's, frontotemporal dementia, hereditary ataxias) Identification of therapeutic targets for fatal neurodegenerative disorders Neuropathological and biomarker studies Recent scholarly trends emphasize: Genetic risk loci mapping via GWAS Proteomic and metallomic analysis of dementia Development of drug-like antibodies for amyloid fibrils Longitudinal studies of ataxia progression Scientific Awards: Landis Outstanding Mentor Award (NIH) Member, National Academy of Medicine Elected Fellow, AAAS Grants and Collaborations: NIH-funded studies on transposable elements in Alzheimer's Multi-institutional projects with Mayo Clinic and University of Chicago Research on metal exposure and dementia trajectories

Catherine M. SteinView profile

Professor

• Tuberculosis Genetics
• Speech-Sound Disorder Genetics
• Genetic Epidemiology
• +4 more

Dr. Catherine M. Stein serves as Professor in the Department of Population and Quantitative Health Sciences at Case Western Reserve University School of Medicine, where she directs research on tuberculosis genomics and developmental speech disorders. Her work bridges genetic epidemiology, biostatistics, and clinical translation through international collaborations in Uganda and South Africa. Education Ph.D. in Epidemiology and Biostatistics, Case Western Reserve University (2004) Research Focus : Dr. Stein's program investigates tuberculosis susceptibility through host-pathogen genomic interactions, particularly in HIV-coinfected populations, and speech-sound disorder etiology via cognitive domain modeling and genetic mapping. Her development of strum R software enables advanced structural equation modeling for family-based genetic studies, featured in Nature Medicine and American Journal of Speech-Language Pathology publications. Publication Trends : Recent work demonstrates methodological innovation in genetic epidemiology (40% in top-tier journals) with 54% international collaboration. Key themes include biomarker discovery for TB exposure, longitudinal outcomes of speech disorders, and ethical frameworks for genomic secondary findings. Mentorship & Funding : She has trained 30 Master's students (5 mentored), 5 PhD candidates, and 1 postdoc, with alumni at Eli Lilly, NIOSH, and NYC Public Health. Current grants include NIH R01s on TB resistance in HIV+ subjects (Uganda/South Africa), NIDCD-funded speech disorder genetics, and Gates Foundation research on pediatric infection recovery. Professional Engagement : Dr. Stein serves as Associate Editor for International Journal of Tuberculosis and Lung Disease and Biomed Central Infectious Diseases , with editorial board membership at Genes Immunity . She actively contributes to the American Society of Human Genetics Social Issues Committee.

• Psychiatry
• Medical Education
• Bioethics
• +5 more

David B. Mallott, MD serves as an Adjunct Associate Professor in the Department of Psychiatry at the University of Maryland, Baltimore School of Medicine, maintaining a primary academic appointment in Psychiatry with secondary administrative responsibilities. Based in Health Sciences Facility 1, Room 134, he is contactable via dmallott@meded.umaryland.edu and directs institutional communications through primary (410-706-6613) and secondary (410-706-0922) telephone lines alongside dedicated fax services (410-706-7607). His research program exhibits exceptional interdisciplinary range across Psychiatry , Medical Education , Bioethics , and Medical Simulation . Key investigations include emotion-reading mechanisms (2013), psychiatric-metabolic disease intersections (2009), and cognitive simulation frameworks for clinical training (2007, 2005). His scholarship consistently bridges clinical practice with educational innovation, particularly in professionalism development (2006) and affective domain assessment in medical admissions (2006). Publication analysis reveals sustained scholarly productivity from 1984-2013 with thematic evolution from foundational schizophrenia research (1988) and chronobiology (1984) toward contemporary medical education technologies and bioethics integration. His work demonstrates consistent methodological diversity spanning historical clinicopathological conferences (1998), pharmacological studies (1990), and cognitive modeling approaches. Administrative engagement is evidenced through his secondary appointment in Administration, though specific leadership roles remain unspecified. While advising activities and grant funding details are unreported in available sources, his institutional presence spans clinical psychiatry, educational innovation, and academic administration within the School of Medicine ecosystem.

Jason WolffView profile

Professor

• Autism spectrum disorder
• Intellectual and developmental disabilities
• Restricted and repetitive behaviors
• +3 more

Jason Wolff is the William Harris Professor in Child Development and a Professor in the Department of Educational Psychology at the University of Minnesota , where he also serves as Director of Graduate Studies. His work focuses on optimizing support for young children with autism and related developmental disabilities. Education: PhD, University of Minnesota BA, University of Chicago Research Interests: Dr. Wolff’s research integrates brain, behavior, and intervention to understand and ameliorate sensory features and restricted/repetitive behaviors during the first years of life. His lab pursues two interrelated goals: (1) characterizing behavioral and brain development in children with autism and related disabilities, and (2) translating these insights into novel, optimally-timed early interventions that improve quality of life. Publication trends from 2014–2023 reveal a consistent focus on longitudinal neuroimaging of infants and toddlers at high risk for autism, quantitative assessment of repetitive behaviors, and early biomarker discovery to predict later clinical outcomes. Collectively, these studies span neurodevelopmental genetics (e.g., fragile X syndrome), neuroanatomical change (corpus callosum, white matter circuitry), and the emergence of sensory and behavioral phenotypes. Scientific Awards: No specific awards are listed in the provided text. Advising & Grants: While individual students are not named, Dr. Wolff directs graduate studies in Educational Psychology and leads a multidisciplinary lab that collaborates with the IBIS Network and other longitudinal cohort studies investigating the developmental origins of autism. Labs & Teams: He heads a research lab within the Department of Educational Psychology that conducts longitudinal neuroimaging and behavioral studies, partnering with national consortia to recruit infant siblings of children with autism and track neurodevelopmental trajectories from 6 months of age onward.

Scot Kristian HillView profile

Professor

• Psychosis
• Schizophrenia
• Neuropsychology
• +5 more

Dr. Scot Kristian Hill is a Professor in the Department of Psychology within Rosalind Franklin University's College of Health Professions, specializing in clinical neuropsychology and psychosis research. His work integrates neuroimaging, genetic analysis, and cognitive testing to investigate neurocognitive deficits in schizophrenia and related disorders. Education PhD in School Psychology, Ball State University (specializing in Clinical Neuropsychology) Postdoctoral Fellowship, Thomas Jefferson University Hospital Postdoctoral Fellowship, Brain Behavior Laboratory, University of Pennsylvania School of Medicine Research Focus : Dr. Hill's laboratory investigates the neural mechanisms of working memory dysfunction in psychosis, with emphasis on frontostriatal communications and electrophysiological markers. His team develops digital neuropsychological assessment tools and examines intermediate phenotypes across psychotic disorders using multimodal approaches including EEG, fMRI, and genetic analyses. Current projects explore cognitive heterogeneity in first-episode psychosis and neurotransmitter regulation at genetic and systems levels. Publication Trends : Recent work shows increasing focus on digital assessment tools (e.g., web-based performance validity tests), cognitive heterogeneity within diagnostic categories, and gene-treatment interactions in psychosis. Collaborative studies through the B-SNIP consortium dominate his schizophrenia research, while methodological innovations characterize his neuropsychological assessment publications. Awards NIMH National Research Service Award Fellowship NIMH Mentored Patient-Oriented Research Career Development Award NIH Clinical Research Loan Repayment Program Award Mentorship & Funding : Dr. Hill has trained 16 PhD graduates and currently supervises 5 graduate students across clinical psychology and counseling programs. His grant portfolio includes NIMH-funded investigations of neurocognition in first-episode schizophrenia, shared genetic liability in psychotic disorders, and cognitive effects of antipsychotic medications, with recent emphasis on digital phenotyping and tele-neuropsychology. Research Infrastructure : He leads the RFU Psychosis Research Laboratory and serves as a core investigator in the multi-site Bipolar and Schizophrenia Network on Intermediate Phenotypes (B-SNIP), conducting large-scale studies of cognitive and neurobiological markers across the psychosis spectrum.

• Neurodevelopmental Disorders
• Neuropsychiatric Disorders
• Autism Spectrum Disorders
• +10 more

David Evans is a Professor of Psychology at Bucknell University with extensive research in neurodevelopmental and neuropsychiatric disorders. His work emphasizes the continuity between typical and atypical development, with particular focus on conditions with known genetic origins including 16p11.2 deletions/duplications, Prader-Willi syndrome, and Down syndrome. Dr. Evans received his Ph.D. from Boston University in 1993 following an M.A. from Tufts University. He completed a postdoctoral fellowship at Yale University (1993-1995) and is currently a Life Member at Clare Hall, University of Cambridge (2018-present). His research examines neurodevelopmental disorders using behavioral measures, neuropsychological tools, and neuroimaging. He has developed dimensional assessment tools for repetitive behaviors and psychosis-spectrum traits. His work spans autism spectrum disorders, Down syndrome, and other genetic conditions, with a focus on understanding the relationship between genetic variations and behavioral phenotypes. Analysis of his recent publications reveals a strong focus on dimensional approaches to neurodevelopmental conditions, with emphasis on repetitive behaviors, psychosis-spectrum traits, and the development of assessment tools. His work increasingly incorporates genetic approaches and examines both children and parents to understand familial patterns. Principal Investigator: Obsessive-compulsive and psychotic-like behaviors across PWS subtypes (2024-2025, $72,984) Principal Investigator: Dimensional analysis of developmental brain disorders using an online, genome-first approach (funded, $3,214,302) Principal Investigator: Functional Imaging and the autism endophenotype (Bucknell-Geisinger, $147,991) Investigator: Comprehensive phenotypic characterization of the 17q12 deletion syndrome (SFARI, $250,000) Dr. Evans teaches courses including Introduction to Psychology, Developmental Psychobiology, Abnormal Psychology, Developmental Psychopathology, Neurodevelopmental Disorders, and Applied Research Methods. He is currently on sabbatical during the 2024-2025 academic year and welcomes undergraduate and graduate students with interests in neuroscience, genetics, and computational sciences to contact him for research opportunities.

Jed ElisonView profile

Professor

• Developmental social neuroscience
• Structural brain development and social cognition
• Visual attention
• +6 more

Jed Elison is a Professor at the Institute of Child Development within the College of Education and Human Development at the University of Minnesota . He is renowned for his work in developmental social neuroscience, focusing on neural mechanisms of early social communication and autism pathogenesis. He serves as a co-investigator for the Infant Brain Imaging Study (IBIS) , funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development , and contributes to major neuroimaging projects like the UNC/UMN Baby Connectome Project (BCP) . BA , Psychology and English, University of Utah (2005) PhD , Psychology, University of North Carolina - Chapel Hill (2011) Postdoc , Social Neuroscience, California Institute of Technology (2013) Elison’s research centers on developmental social neuroscience, structural brain development, social cognition, and early autism identification using neuroimaging (MRI, DWI). His work explores how visual attention and white matter organization influence social communication in infants and toddlers, with implications for autism and emerging psychopathology. Recent publications emphasize longitudinal trajectories of gestural language, brain-behavior associations, and neurodevelopmental heterogeneity. His scientific accolades include the Irving B. Harris Professor of Child Development and Distinguished McKnight University Professor titles. Elison actively mentors graduate students and collaborates with interdisciplinary teams in the Cognition and Neurodevelopmental Studies Lab .

Nicolas BerthelotView profile

Professor

• Child abuse and neglect
• Developmental psychopathology
• Intergenerational transmission of child abuse
• +5 more

Nicolas Berthelot is a full professor in mental health at the Department of Nursing of Université du Québec à Trois-Rivières (UQTR). Holding the Canada Research Chair on Developmental Trauma, he is also a clinical psychologist working with adolescents and adults. His affiliations include being a regular researcher at the Centre de recherche interdisciplinaire sur le développement de l'enfant et la famille (CEIDEF), a regular researcher at the Groupe de recherche et d'intervention auprès des enfants vulnérables et négligés (GRIN), and an associate researcher at the Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec (CRIUSMQ). Research Focus: Developmental mechanisms of risk, resilience, and psychopathology in childhood trauma Intergenerational impacts of child maltreatment Personalized clinical interventions for survivors of child abuse or neglect Prevention of psychological and physical health problems in trauma survivors Neurobiological endophenotypes for psychiatric disorders Publication Trends (2024): Berthelot's recent work explores cannabis effects on parental trauma, trauma resolution mechanisms, mentalization-based interventions during pregnancy, and neurobiological markers in schizophrenia risk. His research spans clinical psychology, developmental neuroscience, and public health, with a focus on intergenerational transmission and maternal mental health. Scientific Awards: UQTR's Prix Relève Scientifique (2019) Réseau des Universités du Québec's Prix d'excellence de la relève (2018) Grants & Collaborations: In 2017, he received a $940,832 grant from the Canada Public Health Agency for a project supporting parents with childhood trauma. He collaborates with multidisciplinary teams including researchers from Cervo research centre, CEIDEF, GRIN, and CRIUSMQ. Labs & Teams: Leads the STEPPROJECT lab (www.stepproject.ca), focusing on developmental trauma research. Works with teams at CEIDEF, GRIN, and CRIUSMQ to translate findings into clinical practices for trauma survivors.

Paul AuerView profile

Professor

• Statistical Genetics
• Genomics
• Bioinformatics
• +3 more

Paul Auer, PhD, is a Professor in the Data Science Institute and leads the Biostatistics Shared Resource at the Medical College of Wisconsin's Cancer Center. He holds a PhD from Purdue University (2010), MPS from Cornell (2003), and BA from SUNY Geneseo (2001). His research focuses on statistical genetics, whole-genome sequencing, and multi-omic data analysis, particularly in complex diseases like cancer, heart disease, and stroke. Collaborations span physiology, blood marrow transplant research, and cancer centers. Key research interests include clonal mosaicism detection, predictive modeling of disease outcomes, and integrating multi-omic data. Recent work emphasizes polygenic risk scores for clinical endpoints and epigenetic correlates of trauma. He directs a lab advancing statistical methods for large-scale genomic studies. Publications (2024-2025) highlight studies on BRCA variants, von Willebrand disease genetics, and hematopoietic transplantation outcomes. Notable projects include EndoPRS methodology and analysis of telomere dynamics in transplant recipients. His work frequently uses TOPMed consortium data for multi-ethnic genomic analyses.

Marylyn RitchieView profile

Professor

• Genetics
• Genomics
• Bioinformatics
• +12 more

Marylyn Ritchie serves as Professor of Genetics while holding key leadership positions including Vice Dean of Artificial Intelligence and Computing, Director of the Institute for Biomedical Informatics, and Co-Director of the Department of Biostatistics, Epidemiology and Informatics. Her work bridges computational methods with clinical genomics to address complex biomedical challenges through translational research. Her research program focuses on big data analysis in genetics and genomics, developing advanced bioinformatics approaches for polygenic risk scoring, multi-omics integration, and machine learning applications. She emphasizes inclusive research design through diverse population studies and addresses health disparities in genetic testing access. Current work includes developing ancestry-specific risk prediction models and fair AI diagnostics for neurodegenerative and ophthalmic conditions. Recent publications (2025) demonstrate leadership in Alzheimer's disease AI diagnostics, glaucoma genetics in African populations, hidradenitis suppurativa genomics, and cardiovascular risk modeling. She pioneers methods for enhancing polygenic score performance across ancestries while addressing ethical considerations in AI-driven healthcare. Professional recognition includes: Fellow of the American College of Medical Informatics (FACMI) Her administrative leadership in directing the Institute for Biomedical Informatics and Center for Translational Bioinformatics indicates active mentorship and research direction, though specific student lists and grant details aren't provided in available materials. She leads interdisciplinary teams in the Institute for Biomedical Informatics and Center for Translational Bioinformatics, developing computational tools for precision medicine implementation and advancing methods for translating genomic discoveries into clinical practice through multi-omics data integration.

• Psychiatry
• Neuroimaging
• Genetics
• +5 more

Dr. David Glahn is the Associate Chief for Research in the Department of Psychiatry at Boston Children's Hospital and Harvard Medical School, where he directs the Tommy Fuss Center for Neuropsychiatric Disease Research, the Early Psychosis Investigation Center (EPICenter), and the Neuropsychiatric Genetics Program (NPG). He received his PhD in Clinical Psychology from the University of Pennsylvania and completed a post-doctoral fellowship at the University of California at Los Angeles. Prior to joining Boston Children's Hospital and Harvard Medical School, Dr. Glahn served as Co-Director for the Division of Neurocognition, Neurocomputation, and Neurogenetics at the Yale University School of Medicine. Dr. Glahn's research program centers on discovering genes and environmental mechanisms that predispose individuals to affective and psychotic disorders across the lifespan. His work develops and applies neuroanatomic, functional neuroimaging, and neurocognitive endophenotypes in large-scale family-based studies. His research involves four broad scientific aims: identifying genes influencing risk for psychotic and affective disorders; specifying genetic and environmental influences on brain structure/function and cognitive ability; isolating factors involved in human cognitive and brain development during adolescence; and developing novel endophenotypes for psychiatric disorders. His recent publications demonstrate a strong focus on neuroimaging genetics, particularly examining structural brain differences across psychiatric disorders, the role of copy number variants in brain morphology, and the development of reference curves for brain metrics across the lifespan. His work often involves large-scale consortium efforts like ENIGMA, highlighting his collaborative approach to psychiatric research. Dr. Glahn's research has significant implications for early identification of psychosis risk and potential interventions to mitigate the development of full-blown disease by recognizing antecedents in young children. Dr. Glahn has received recognition for his contributions to understanding the genetic architecture of brain structure and function, with particular emphasis on developmental aspects of psychiatric disorders. His work bridges basic neuroscience with clinical applications, aiming to translate findings into improved diagnostic and intervention strategies. As a leader in the field, Dr. Glahn mentors junior researchers and collaborates extensively across institutions. His laboratory serves as a hub for innovative research on the biological underpinnings of psychiatric disorders, with particular focus on early identification and prevention strategies. His work on the gut-brain axis and somatic symptoms in psychosis represents innovative directions in understanding the complex interplay between physical and mental health in psychiatric conditions.

Paula G. WilliamsView profile

Professor

• Health Psychology
• Clinical Psychology
• Stress Regulation
• +4 more

Paula G. Williams, Ph.D., is a Professor in the Department of Psychology at the University of Utah. Her research focuses on individual differences in risk and resilience for adverse mental and physical health outcomes, particularly examining the interplay between personality, cognitive functioning, and psychophysiological factors like respiratory sinus arrhythmia (RSA). She has a dual emphasis on stress regulation (exposure, reactivity, recovery, restoration) and the health impacts of aesthetic engagement (art, nature, beauty). Education: Ph.D., University of Utah (Clinical Psychology, 1995) M.S., Illinois State University (Clinical Psychology, 1988) B.S., University of Illinois (Psychology/Genetics and Development, 1986) Internship & Postdoctoral Fellowship, Duke University Medical Center (Clinical Psychology, 1993–1996) Research Interests: Williams investigates how personality traits (e.g., Openness to Experience), executive functioning, and RSA interact to influence stress regulation and health outcomes. Her work bridges clinical psychology and health psychology, with recent trends focusing on: Phenotypic and endophenotypic characteristics of habitual short sleepers Individual differences in aesthetic engagement and their relationship to awe, stress resilience, and growth orientation Psychosomatic pathways linking sleep quality to telomere length and cardiovascular risk Article Trends: Her recent publications emphasize: Multidisciplinary methods combining actigraphy, fMRI, and self-report Perinatal sleep patterns and emotional dysregulation Personality facets as mediators in insomnia and bedtime procrastination Functional connectivity in aesthetic experiences and stress resilience Biopsychosocial models of sleep health and aging Advising & Collaborations: Williams actively mentors graduate students including Steven Carlson, Tuan Cassim, and Kimberley Johnson. She collaborates with researchers like Yana Suchy, Timothy W. Smith, and Brian R. W. Baucom, spanning projects on neural reward processing, executive functioning, and pandemic-related coping mechanisms.

• Bipolar Disorder
• Psychiatric Genetics
• Proteomics
• +5 more

Lina Jonsson is a researcher at the Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg. Her work bridges psychiatric genetics, proteomics, and neurochemistry to advance understanding of bipolar disorder and related conditions. Key Research Areas: Bipolar disorder genomics, cerebrospinal fluid proteomics, polygenic risk scores, and longitudinal studies via the St. Göran Project Recent Contributions: 2025 studies on fine-mapping risk genes, proteome mapping, and multi-omics approaches for bipolar disorder; 2024 work on ADCY1 gene implications and cohort profiling Contact: Lina.Jonsson@neuro.gu.se

Ran TaoView profile

Associate Professor

• Biostatistics
• Genomics
• Polygenic Risk Scores
• +3 more

Ran Tao is an Associate Professor of Biostatistics at the Department of Biostatistics, Vanderbilt University Medical Center. Their research focuses on advanced statistical methods for genomic and proteomic data analysis, with particular emphasis on pharmacogenetics, polygenic risk prediction, and multi-ancestry genetic studies. Research Highlights : Development of the sleev R package for error-in-variables likelihood estimation Innovative approaches for integrating endophenotypes into polygenic risk scoring (EndoPRS) Leadership in multi-ethnic GWAS studies for breast cancer, kidney disease, and cardiovascular outcomes Expertise in two-phase study designs and longitudinal data analysis Key Collaborations : Works closely with the Million Veteran Program (MVP) and participates in global biobank initiatives. Methodological Interests : Their work spans Mendelian randomization, multi-omics integration, and causal association modeling across diverse populations.

Diana ArmbrusterView profile

Researcher

• Genetic variation
• Environmental factors
• Personality trait development
• +4 more

Diana Armbruster is a researcher at the Department of Psychology, Faculty of Science, Dresden University of Technology. Her work focuses on gene-environment interactions in emotional processing and personality development. 2010 PhD in Psychology (summa cum laude), TU Dresden 2005 Diploma in Psychology (sehr gut), TU Dresden Research Interests: Armbruster investigates how genetic variations (serotonergic/dopaminergic systems) and environmental factors interact to shape personality traits and emotional processing. Her studies examine endophenotypes linking biological mechanisms to behavior, with recent emphasis on intraindividual variability in genetic responses. Publication Trends: Her 2009-2018 articles span Psychoneuroendocrinology , Behavioral Neuroscience , and Physiology & Behavior , covering topics like Stress response mechanisms Menstrual cycle influences on physiology Genetic polymorphisms in emotional regulation Age-related differences in stress resilience Scientific Honors: 2012 Commerzbankpreis for doctoral thesis